glp-1 receptor agonists and next-generation metabolic hormone therapies in chronic kidney disease Current Insights, Advantages and Challenges

[DOI] [Google Scholar] 119.Urkon M., Ferencz E., Szsz J.A., Szabo M.I.M., Orbn-Kis K., Szatmri S., Nagy E.E

19 Given the possibility that existing GLP-1 drugs are insufficient for treating Alzheimers and Parkinsons disease, some researchers are studying new versions of GLP-1s designed to solve that exact problem

The hypoglycemia risk comes from the older medicines it sits alongside, which is why insulin and sulfonylurea doses are usually reduced first

doi:10.1016/j.eclinm.2024.102624 Palermo A, DOnofrio L, Eastell R, Schwartz AV, Pozzilli P, Napoli N

In physique sports and everyday gym culture the definition phase refers to a period of several weeks or months when the goal shifts from building mass to revealing existing muscle

In the same 2025 study by Qeadan and colleagues, individuals with a history of opioid use disorder (n=503,747) prescribed GLP-1 medications had about a 40% lower rate of opioid overdose events during the 2-year follow-up period (Qeadan et al., 2025)